{
  "$schema": "https://github.com/Open-Systems-Pharmacology/QualificationPlan/releases/download/v2.1/OSP_Qualification_Plan_Schema.json",
  "Projects": [
    {
      "Id": "Alfentanil",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Alfentanil-Model/v2.0/Alfentanil-Model.json"
    },
    {
      "Id": "Alprazolam",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Alprazolam-Model/v1.0/Alprazolam-Model.json"
    },
    {
      "Id": "Clarithromycin",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Clarithromycin-Model/v1.0/Clarithromycin-Model.json"
    },
    {
      "Id": "Efavirenz",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Efavirenz-Model/v1.0/Efavirenz-Model.json"
    },
    {
      "Id": "Erythromycin",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Erythromycin-Model/v1.0/Erythromycin-Model.json"
    },
    {
      "Id": "Fluvoxamine",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Model/v1.0/Fluvoxamine-Model.json"
    },
    {
      "Id": "Itraconazole",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Model/v1.1/Itraconazole-Model.json"
    },
    {
      "Id": "Midazolam",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Midazolam-Model/v1.0/Midazolam-Model.json"
    },
    {
      "Id": "Rifampicin",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Model/v1.0/Rifampicin-Model.json"
    },
    {
      "Id": "Triazolam",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Triazolam-Model/v1.0/Triazolam-Model.json"
    },
    {
      "Id": "Verapamil",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Verapamil-Model/v1.0/Verapamil-Model.json"
    },
    {
      "Id": "Clarithromycin-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Clarithromycin-Midazolam-DDI/v1.0/Clarithromycin-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Clarithromycin",
          "Project": "Clarithromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet Clarithromycin",
          "Project": "Clarithromycin"
        },
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008a",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - iv - Quinney 2008",
            "DDI Control - Midazolam - po - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "DDI Treatment - Clarithromycin/Midazolam - van Dyk 2018"
          ]
        },
        {
          "Project": "Clarithromycin",
          "Simulation": "Clarithromycin po, Chu 1992, 100 mg",
          "Path": "Clarithromycin|P (blood cells->plasma)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5"
          ]
        },
        {
          "Project": "Clarithromycin",
          "Simulation": "Clarithromycin po, Chu 1992, 100 mg",
          "Path": "Clarithromycin|P (plasma->blood cells)",
          "TargetSimulations": [
            "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5"
          ]
        }
      ]
    },
    {
      "Id": "Clarithromycin-Triazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Clarithromycin-Triazolam-DDI/v1.0/Clarithromycin-Triazolam_DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Triazolam",
          "Project": "Triazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Halcion",
          "Project": "Triazolam"
        },
        {
          "Type": "Compound",
          "Name": "Clarithromycin",
          "Project": "Clarithromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet Clarithromycin",
          "Project": "Clarithromycin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Clarithromycin",
          "Simulation": "Clarithromycin po, Chu 1992, 100 mg",
          "Path": "Clarithromycin|P (blood cells->plasma)",
          "TargetSimulations": [
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        },
        {
          "Project": "Clarithromycin",
          "Simulation": "Clarithromycin po, Chu 1992, 100 mg",
          "Path": "Clarithromycin|P (plasma->blood cells)",
          "TargetSimulations": [
            "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO"
          ]
        }
      ]
    },
    {
      "Id": "Erythromycin-Alfentanil-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Erythromycin-Alfentanil-DDI/v1.0/Erythromycin-Alfentanil-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Alfentanil",
          "Project": "Alfentanil"
        },
        {
          "Type": "Compound",
          "Name": "Erythromycin",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_enteric-coated-tablet",
          "Project": "Erythromycin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Bartkowski1989_Control",
            "Bartkowski1989_Perpetrator_Day7",
            "Bartkowski1989_Perpetrator_Day1"
          ]
        }
      ]
    },
    {
      "Id": "Erythromycin-Alprazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Erythromycin-Alprazolam-DDI/v1.0/Erythromycin-Alprazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Individual",
          "Name": "Japanese (Yasui studies)",
          "Project": "Alprazolam"
        },
        {
          "Type": "Compound",
          "Name": "Alprazolam",
          "Project": "Alprazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Xanax_IR",
          "Project": "Alprazolam"
        },
        {
          "Type": "Compound",
          "Name": "Erythromycin",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_filmtablet",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Solanax",
          "Project": "Alprazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui1996_Control",
            "Yasui1996_Perpetrator"
          ]
        }
      ]
    },
    {
      "Id": "Erythromycin-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Erythromycin-Midazolam-DDI/v1.0/Erythromycin-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Erythromycin",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_filmtablet",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_filmtablet_250mg",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_enteric-coated-tablet",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_enteric-coated-pellets",
          "Project": "Erythromycin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Control_Carls2014",
            "Control_Okudaira2007_EM0",
            "Control_Olkkola1993_IV",
            "Control_Olkkola1993_Oral",
            "Control_Swart2002",
            "Control_Zimmermann1996",
            "Treatment_Carls2014_1000mg",
            "Treatment_Carls2014_250mg",
            "Treatment_Okudaira2007_EM2",
            "Treatment_Okudaira2007_EM4",
            "Treatment_Okudaira2007_EM7",
            "Treatment_Olkkola1993_IV",
            "Treatment_Olkkola1993_Oral",
            "Treatment_Swart2002",
            "Treatment_Zimmermann1996"
          ]
        }
      ]
    },
    {
      "Id": "Erythromycin-Triazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Erythromycin-Triazolam-DDI/v1.0/Erythromycin-Triazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Triazolam",
          "Project": "Triazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Halcion",
          "Project": "Triazolam"
        },
        {
          "Type": "Compound",
          "Name": "Erythromycin",
          "Project": "Erythromycin"
        },
        {
          "Type": "Formulation",
          "Name": "Erythromycin_Weibull_enteric-coated-tablet",
          "Project": "Erythromycin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Greenblatt1998_Control",
            "Greenblatt1998_Perpetrator",
            "Phillips1986_Control",
            "Phillips1986_Perpetrator"
          ]
        }
      ]
    },
    {
      "Id": "Fluvoxamine-Alprazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Alprazolam-DDI/v1.0/Fluvoxamine-Alprazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        },
        {
          "Type": "Compound",
          "Name": "Alprazolam",
          "Project": "Alprazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Xanax_IR",
          "Project": "Alprazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Solanax",
          "Project": "Alprazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Fleishaker1994_Alprazolam",
            "Fleishaker1994_Fluvoxamine_Alprazolam"
          ]
        }
      ]
    },
    {
      "Id": "Fluvoxamine-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Fluvoxamine-Midazolam-DDI/v1.0/Fluvoxamine-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Fluvoxamine",
          "Project": "Fluvoxamine"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Lam 2003, 10 mg, SD, midazolam control",
            "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "DDI Control - Midazolam - Kashuba 1998"
          ]
        }
      ]
    },
    {
      "Id": "Itraconazole-Alprazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Alprazolam-DDI/v1.0/Itraconazole-Alprazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Individual",
          "Name": "Japanese (Yasui studies)",
          "Project": "Alprazolam"
        },
        {
          "Type": "Compound",
          "Name": "Alprazolam",
          "Project": "Alprazolam"
        },
        {
          "Type": "Compound",
          "Name": "Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Hydroxy-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Keto-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "N-desalkyl-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fasted",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fed",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Xanax_IR",
          "Project": "Alprazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Solanax",
          "Project": "Alprazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Yasui 1998 - Alprazolam 0.8 mg with itraconazole"
          ]
        }
      ]
    },
    {
      "Id": "Itraconazole-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Midazolam-DDI/v1.0/Itraconazole-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Individual",
          "Name": "Korean (Yu 2004 study)",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Hydroxy-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Keto-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "N-desalkyl-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fasted",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fed",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Olkkola 1994",
            "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "DDI Control - Midazolam - Ahonen 1995",
            "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "DDI Control - Midazolam - Templeton 2010",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)"
          ]
        }
      ]
    },
    {
      "Id": "Itraconazole-Triazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Itraconazole-Triazolam-DDI/v1.0/Itraconazole-Triazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Triazolam",
          "Project": "Triazolam"
        },
        {
          "Type": "Compound",
          "Name": "Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Hydroxy-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "Keto-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Compound",
          "Name": "N-desalkyl-Itraconazole",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fasted",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Capsule fed",
          "Project": "Itraconazole"
        },
        {
          "Type": "Formulation",
          "Name": "Halcion",
          "Project": "Triazolam"
        },
        {
          "Type": "Event",
          "Name": "Standard Meal",
          "Project": "Itraconazole"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Varhe 1994 - Triazolam 0.25 mg control",
            "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD"
          ]
        }
      ]
    },
    {
      "Id": "Verapamil-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Verapamil-Midazolam-DDI/v1.0/Verapamil-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Verapamil",
          "Project": "Verapamil"
        },
        {
          "Type": "Formulation",
          "Name": "controlled release",
          "Project": "Verapamil"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Control - Midazolam - Wang 2005",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Verapamil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        },
        {
          "Project": "Verapamil",
          "Simulation": "Barbarash 1988 + Johnston 1981 + McAllister 1982 +Hla 1987 (120 mg PO SD)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Verapamil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "DDI Treatment - Verapamil/Midazolam - Wang 2005"
          ]
        }
      ]
    },
    {
      "Id": "Efavirenz-Alfentanil-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Efavirenz-Alfentanil-DDI/v1.0/Efavirenz-Alfentanil-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Efavirenz",
          "Project": "Efavirenz"
        },
        {
          "Type": "Formulation",
          "Name": "Sustiva",
          "Project": "Efavirenz"
        },
        {
          "Type": "Compound",
          "Name": "Alfentanil",
          "Project": "Alfentanil"
        },
        {
          "Type": "Formulation",
          "Name": "Solution",
          "Project": "Alfentanil"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2004, Alfentanil po 0.06 mg/kg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 2012, Alfentanil IV alone",
            "Kharasch 2012, Alfentanil PO alone",
            "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD"
          ]
        }
      ]
    },
    {
      "Id": "Efavirenz-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Efavirenz-Midazolam-DDI/v1.0/Efavirenz-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Efavirenz",
          "Project": "Efavirenz"
        },
        {
          "Type": "Formulation",
          "Name": "Sustiva",
          "Project": "Efavirenz"
        },
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Mikus 2017, Midazolam alone",
            "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Katzenmaier 2010, Midazolam alone",
            "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD"
          ]
        }
      ]
    },
    {
      "Id": "Rifampicin-Alfentanil-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Alfentanil-DDI/v1.0/Rifampicin-Alfentanil-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Alfentanil",
          "Project": "Alfentanil"
        },
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        },
        {
          "Project": "Alfentanil",
          "Simulation": "Kharasch 2011b, Alfentanil PO 4 mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alfentanil|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Kharasch 1997 20 µg/kg IV - control",
            "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Kharasch 2004 15 µg/kg IV - control",
            "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Kharasch 2004 60 µg/kg PO - control",
            "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Kharasch 2011 15 µg/kg IV - control",
            "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO - control",
            "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Kharasch 2011b IV 1mg - control",
            "Kharasch 2011b PO 4mg - control",
            "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Phimmasone 2001 15 µg/kg IV - control",
            "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin"
          ]
        }
      ]
    },
    {
      "Id": "Rifampicin-Alprazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Alprazolam-DDI/v1.0/Rifampicin-Alprazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        },
        {
          "Type": "Compound",
          "Name": "Alprazolam",
          "Project": "Alprazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Xanax_IR",
          "Project": "Alprazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        },
        {
          "Project": "Alprazolam",
          "Simulation": "PO_0.5mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Alprazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Gashaw 2003 - Alprazolam control",
            "Gashaw 2003 - Alprazolam + Rifampicin",
            "Schmider 1999 - Alprazolam control",
            "Schmider 1999 - Alprazolam + Rifampicin"
          ]
        }
      ]
    },
    {
      "Id": "Rifampicin-Midazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Midazolam-DDI/v1.0/Rifampicin-Midazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Individual",
          "Name": "Korean (Yu 2004 study)",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Midazolam",
          "Project": "Midazolam"
        },
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        },
        {
          "Type": "Formulation",
          "Name": "Tablet (Dormicum)",
          "Project": "Midazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        },
        {
          "Project": "Midazolam",
          "Simulation": "po 3 mg (solution)",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Midazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "DDI Control - Midazolam - Backman 1996",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "DDI Control - Midazolam - Backman 1998",
            "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "DDI Control - Midazolam - Chung 2006",
            "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "DDI Control - Midazolam - Eap 2004 (0.075 mg)",
            "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "DDI Control - Midazolam - Gorski 2003 (iv)",
            "DDI Control - Midazolam - Gorski 2003 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "DDI Control - Midazolam - Gurley 2006",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "DDI Control - Midazolam - Gurley 2008",
            "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "DDI Control - Midazolam - Kharasch 2004 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "DDI Control - Midazolam - Kharasch 2011 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "DDI Control - Midazolam - Link 2008 (iv)",
            "DDI Control - Midazolam - Link 2008 (po)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "DDI Control - Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "DDI Control - Midazolam - Szalat 2007",
            "DDI Control - Midazolam - van Dyk 2018",
            "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "DDI Control - Midazolam - Prueksaritanont 2017",
            "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "DDI Control - Midazolam - Shin 2013",
            "DDI Control - Midazolam - Shin 2016",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "DDI Control - Midazolam - Kim 2018 (male)",
            "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "DDI Control - Midazolam - Kharasch 1997",
            "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "DDI Control - Midazolam - Wiesinger 2020",
            "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020"
          ]
        }
      ]
    },
    {
      "Id": "Rifampicin-Triazolam-DDI",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Rifampicin-Triazolam-DDI/v1.0/Rifampicin-Triazolam-DDI.json",
      "BuildingBlocks": [
        {
          "Type": "Compound",
          "Name": "Rifampicin",
          "Project": "Rifampicin"
        },
        {
          "Type": "Compound",
          "Name": "Triazolam",
          "Project": "Triazolam"
        },
        {
          "Type": "Formulation",
          "Name": "Halcion",
          "Project": "Triazolam"
        }
      ],
      "SimulationParameters": [
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (interstitial->intracellular)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Duodenum_int_Duodenum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperJejunum_int_UpperJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerJejunum_int_LowerJejunum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|UpperIleum_int_UpperIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|LowerIleum_int_LowerIleum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Caecum_int_Caecum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonAscendens_int_ColonAscendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonTransversum_int_ColonTransversum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonDescendens_int_ColonDescendens_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|ColonSigmoid_int_ColonSigmoid_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        },
        {
          "Project": "Triazolam",
          "Simulation": "PO_0.125mg",
          "Path": "Neighborhoods|Rectum_int_Rectum_cell|Triazolam|P (intracellular->interstitial)",
          "TargetSimulations": [
            "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO"
          ]
        }
      ]
    }
  ],
  "ObservedDataSets": [
    {
      "Id": "DDI Ratios",
      "Path": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Database-for-observed-data/v1.0/DDI.csv",
      "Type": "DDIRatio"
    }
  ],
  "Plots": {
    "AxesSettings": {
      "GOFMergedPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "GOFMergedPlotsResidualsOverTime": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Linear"
        }
      ],
      "ComparisonTimeProfile": [
        {
          "Type": "X",
          "Dimension": "Time",
          "Unit": "h",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Concentration (mass)",
          "Unit": "ng/ml",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsPredictedVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "DDIRatioPlotsResidualsVsObserved": [
        {
          "Type": "X",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ],
      "PKRatioPlots": [
        {
          "Type": "X",
          "Dimension": "Age",
          "Unit": "year(s)",
          "GridLines": false,
          "Scaling": "Linear"
        },
        {
          "Type": "Y",
          "Dimension": "Dimensionless",
          "Unit": "",
          "GridLines": false,
          "Scaling": "Log"
        }
      ]
    },
    "PlotSettings": {
      "ChartWidth": 500,
      "ChartHeight": 400,
      "Fonts": {
        "AxisSize": 11,
        "LegendSize": 9,
        "OriginSize": 9,
        "FontFamilyName": "Arial",
        "WatermarkSize": 40
      }
    },
    "AllPlots": [],
    "GOFMergedPlots": [],
    "ComparisonTimeProfilePlots": [
      {
        "SectionId": 301,
        "Title": "Gorski 1998 (midazolam IV)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Gorski 1998, Midazolam 0.05 mg/kg iv",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 1998 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 1998 - iv with Perpetrator (Clarithromycin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Gorski 1998 (midazolam po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Gorski 1998, Midazolam 4 mg po",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 1998 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 1998 - po with Perpetrator (Clarithromycin) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Gurley 2006",
        "SimulationDuration": 6,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - with Perpetrator (Clarithomycin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Gurley 2008a",
        "SimulationDuration": 6,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2008a",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - Control pre-Clarithromycin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - with Perpetrator (Clarithomycin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Markert 2013",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Markert 2013, Midazolam 3 mg po",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Markert 2013 - Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=11)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Markert 2013 - with Perpetrator (Clarithromycin) - Midazolam - PO - 3 mg - Plasma - agg. (n=11)",
            "StartTime": 72.25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Prueksaritanont 2017",
        "SimulationDuration": 48,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail alone - Midazolam - PO - 10 µg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail + Clarithromycin - Midazolam - PO - 10 µg - Plasma - agg. (n=8)",
            "StartTime": 72,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Quinney 2008 (midazolam IV)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - iv - Quinney 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Quinney 2008 - Control iv Midazolam All - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Quinney 2008 - iv Midazolam All after clarithromycin - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Quinney 2008 (midazolam po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - po - Quinney 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Quinney 2008 - Control po Midazolam All - Midazolam - PO - 3.0 - 4.0 mg - Whole Blood - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Quinney 2008 - po Midazolam All after clarithromycin - Midazolam - PO - 3.0 - 4.0 mg - Whole Blood - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "van Dyk 2018",
        "SimulationDuration": 10,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - van Dyk 2018",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "van Dyk 2018 - Midazolam in Caucasian at baseline - Midazolam - PO - 1 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 324,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 301,
        "Title": "Yeates 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Yeates 1996, Midazolam 15 mg po",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yeates 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Midazolam-DDI",
            "Simulation": "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yeates 1996 - with Perpetrator (Clarithromycin) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
            "StartTime": 97.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 302,
        "Title": "Greenblatt 1998a",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Clarithromycin-Triazolam-DDI",
            "Simulation": "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Greenblatt 1998a - Triazolam + Placebo (Trial B) - Triazolam - PO - 0.125 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Clarithromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Clarithromycin-Triazolam-DDI",
            "Simulation": "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Greenblatt 1998a - Triazolam + Clarithromycin (Trial E) - Triazolam - PO - 0.125 mg - Plasma - agg. (n=12)",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Clarithromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 303,
        "Title": "Bartkowski 1989",
        "SimulationDuration": 8,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Alfentanil-DDI",
            "Simulation": "Bartkowski1989_Control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Bartkowski 1989 - Control - Alfentanil - IV - 50 µg/kg - Serum - indiv.",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin) - Individiual 1",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Alfentanil-DDI",
            "Simulation": "Bartkowski1989_Perpetrator_Day1",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Bartkowski 1989 - Treatment Day 1 - Alfentanil - IV - 50 µg/kg - Serum - indiv.",
            "StartTime": 1.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin (Day 1) - Individiual 1",
            "Symbol": "Square"
          },
          {
            "Project": "Erythromycin-Alfentanil-DDI",
            "Simulation": "Bartkowski1989_Perpetrator_Day7",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Bartkowski 1989 - Treatment Day 7 - Alfentanil - IV - 50 µg/kg - Serum - indiv.",
            "StartTime": 145.5,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment with erythromycin (Day 7) - Individiual 1",
            "Symbol": "Triangle"
          }
        ]
      },
      {
        "SectionId": 303,
        "Title": "Bartkowski 1993",
        "SimulationDuration": 8,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Alfentanil-DDI",
            "Simulation": "Bartkowski1989_Control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Bartkowski 1993 - Control - Alfentanil - IV - 50 µg/kg - Serum - indiv.",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin) - Individiual 2",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Alfentanil-DDI",
            "Simulation": "Bartkowski1989_Perpetrator_Day1",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Bartkowski 1993 - Treatment Day 1 - Alfentanil - IV - 50 µg/kg - Serum - indiv.",
            "StartTime": 1.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin (Day 1) - Individiual 2",
            "Symbol": "Square"
          },
          {
            "Project": "Erythromycin-Alfentanil-DDI",
            "Simulation": "Bartkowski1989_Perpetrator_Day7",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Bartkowski 1993 - Treatment Day 7 - Alfentanil - IV - 50 µg/kg - Serum - indiv.",
            "StartTime": 145.5,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment with erythromycin (Day 7) - Individiual 2",
            "Symbol": "Triangle"
          }
        ]
      },
      {
        "SectionId": 304,
        "Title": "Yasui 1996",
        "SimulationDuration": 48,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Alprazolam-DDI",
            "Simulation": "Yasui1996_Control",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui 1996 - Treatment with placebo - Alprazolam - PO - 0.8 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Alprazolam-DDI",
            "Simulation": "Yasui1996_Perpetrator",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui 1996 - Treatment with erythromycin - Alprazolam - PO - 0.8 mg - Plasma - agg. (n=12)",
            "StartTime": 170,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 305,
        "Title": "Carls 2014",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Control_Carls2014",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Carls2014_250mg",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 1,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment with erythromycin (250 mg)",
            "Symbol": "Square"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Carls2014_1000mg",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 1,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin (1000 mg)",
            "Symbol": "Triangle"
          }
        ]
      },      
      {
        "SectionId": 305,
        "Title": "Okudaira 2007",
        "SimulationDuration": 22,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Control_Okudaira2007_EM0",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Okudaira 2007 - EM 0 Control (Perpetrator Placebo) - Midazolam - PO - 2.5 (actually 5) mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Okudaira2007_EM2",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Okudaira 2007 - EM 2 with Perpetrator (Erythromycin) - Midazolam - PO - 2.5 mg - Plasma - agg. (n=12)",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin for 2 days",
            "Symbol": "Square"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Okudaira2007_EM4",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Okudaira 2007 - EM 4 with Perpetrator (Erythromycin) - Midazolam - PO - 2.5 mg - Plasma - agg. (n=12)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment with erythromycin for 4 days",
            "Symbol": "Triangle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Okudaira2007_EM7",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Okudaira 2007 - EM 7 with Perpetrator (Erythromycin) - Midazolam - PO - 2.5 mg - Plasma - agg. (n=12)",
            "StartTime": 145,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment with erythromycin for 7 days",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 305,
        "Title": "Olkkola 1993 (midazolam IV)",
        "SimulationDuration": 18,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Control_Olkkola1993_IV",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1993 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Olkkola1993_IV",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1993 - iv with Perpetrator (Erythromycin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=6)",
            "StartTime": 128,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with erythromycin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 305,
        "Title": "Olkkola 1993 (midazolam po)",
        "SimulationDuration": 18,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Control_Olkkola1993_Oral",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1993 - po Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Olkkola1993_Oral",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1993 - po with Perpetrator (Erythromycin) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
            "StartTime": 128,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with erythromycin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 305,
        "Title": "Swart 2002",
        "SimulationDuration": 4,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Control_Swart2002",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Swart 2002 - day 5 Control (Perpetrator Placebo) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Swart2002",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Swart 2002 - day 10 Control with Perpetrator (Erythromycin) - Midazolam - IV - 0.075 mg/kg - Plasma - agg. (n=8)",
            "StartTime": 96,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with erythromycin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 305,
        "Title": "Zimmermann 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Control_Zimmermann1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Zimmermann 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Midazolam-DDI",
            "Simulation": "Treatment_Zimmermann1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Zimmermann 1996 - with Perpetrator (Erythromycin) - Midazolam - PO - 15 mg - Plasma - agg. (n=12)",
            "StartTime": 97.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with erythromycin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 306,
        "Title": "Greenblatt 1998",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Triazolam-DDI",
            "Simulation": "Greenblatt1998_Control",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Greenblatt 1998a - Triazolam + Placebo (Trial B) - Triazolam - PO - 0.125 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Triazolam-DDI",
            "Simulation": "Greenblatt1998_Perpetrator",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Greenblatt 1998a - Triazolam + Erythromycin (Trial D) - Triazolam - PO - 0.125 mg - Plasma - agg. (n=12)",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 306,
        "Title": "Phillips 1986",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Erythromycin-Triazolam-DDI",
            "Simulation": "Phillips1986_Control",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phillips 1986 - Triazolam alone - Triazolam - PO - 0.5 mg - Plasma - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without erythromycin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Erythromycin-Triazolam-DDI",
            "Simulation": "Phillips1986_Perpetrator",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phillips 1986 - Triazolam after 3 days of erythromycin - Triazolam - PO - 0.5 mg - Plasma - agg. (n=16)",
            "StartTime": 64,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with erythromycin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 307,
        "Title": "Fleishaker 1994 (Day 1, first dose)",
        "SimulationDuration": 5,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Fluvoxamine-Alprazolam-DDI",
            "Simulation": "Fleishaker1994_Alprazolam",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Fleishaker 1994 - Alprazolam alone - Alprazolam - PO - 1 mg - Plasma - agg. (n=20)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Fluvoxamine-Alprazolam-DDI",
            "Simulation": "Fleishaker1994_Fluvoxamine_Alprazolam",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Fleishaker 1994 - Alprazolam + fluvoxamine - Alprazolam - PO - 1 mg - Plasma - agg. (n=20)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 307,
        "Title": "Fleishaker 1994 (Day 10)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Fluvoxamine-Alprazolam-DDI",
            "Simulation": "Fleishaker1994_Alprazolam",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Fleishaker 1994 - Alprazolam alone - Alprazolam - PO - 1 mg - Plasma - agg. (n=20)",
            "StartTime": 72,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Fluvoxamine-Alprazolam-DDI",
            "Simulation": "Fleishaker1994_Fluvoxamine_Alprazolam",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Fleishaker 1994 - Alprazolam + fluvoxamine - Alprazolam - PO - 1 mg - Plasma - agg. (n=20)",
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Fluvoxamine",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 308,
        "Title": "Kashuba 1998",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kashuba 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 517,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Fluvoxamine)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 308,
        "Title": "Lam 2003",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "Lam 2003, 10 mg, SD, midazolam control",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Lam 2003 - Midazolam before Fluvoxamine - Midazolam - PO - 10 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Fluvoxamine)",
            "Symbol": "Circle"
          },
          {
            "Project": "Fluvoxamine-Midazolam-DDI",
            "Simulation": "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Lam 2003 - Midazolam after Fluvoxamine - Midazolam - PO - 10 mg - Plasma - agg. (n=10)",
            "StartTime": 265,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Fluvoxamine)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 309,
        "Title": "Yasui 1998",
        "SimulationDuration": 48,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Alprazolam-DDI",
            "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with placebo",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui 1998 - Alprazolam with placebo - Alprazolam - PO - 0.8 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Alprazolam-DDI",
            "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with itraconazole",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yasui 1998 - Alprazolam with itraconazole - Alprazolam - PO - 0.8 mg - Plasma - agg. (n=10)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Ahonen 1995",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Ahonen 1995",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Ahonen 1995 - Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Ahonen 1995 - with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Backman 1998",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase II (during Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment Phase II (with Itraconazole)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase III (4 days after Perpetrator (Itraconazole)) - Midazolam - PO - 15 (actually 7.5) mg - Plasma - agg. (n=9)",
            "StartTime": 170,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment Phase III (with Itraconazole)",
            "Symbol": "Triangle"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1994",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1994 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1994 - po with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=9)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1996 (day 1 po)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 1 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 1 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 2,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1996 (day 4 iv)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 4 (iv) Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 4 (iv) with Perpetrator (Itraconazole) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=12)",
            "StartTime": 74,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Olkkola 1996 (day 6 po)",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 6 (po) Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Olkkola 1996 - day 6 (po) with Perpetrator (Itraconazole) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=12)",
            "StartTime": 122,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Prueksaritanont 2017",
        "SimulationDuration": 72,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail alone - Midazolam - PO - 10 µg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail + Itraconazole - Midazolam - PO - 10 µg - Plasma - agg. (n=8)",
            "StartTime": 72,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Templeton 2010",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Templeton 2010",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - Control (Perpetrator Placebo) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 50 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with 100 mg Itraconazole)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 200 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with 200 mg Itraconazole)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Templeton 2010 - with Perpetrator (Itraconazole @ 400 mg) - Midazolam - PO - 2 mg - Plasma - agg. (n=6)",
            "StartTime": 4,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 400 mg Itraconazole)",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 310,
        "Title": "Yu 2004 (CYP3A5*3/*3)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yu 2004 - Control CYP3A5*3/*3 - Midazolam - IV - 1 mg - Plasma - agg. (n=7)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Midazolam-DDI",
            "Simulation": "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yu 2004 - Treatment Itraconazole CYP3A5*3/*3 - Midazolam - IV - 1 mg - Plasma - agg. (n=7)",
            "StartTime": 72,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 311,
        "Title": "Neuvonen 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Control phase (Triazolam without Itraconazole) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ simultaneously) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Treatment (Itraconazole administered simultaneously)",
            "Symbol": "Square"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ 3 hr before) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 3,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (Itraconazole administered 3h before)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ 12 hr before) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 12,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (Itraconazole administered 12h before)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Neuvonen 1996 - Treatment phase (triazolam + ITZ 24 hr before) - Triazolam - PO - 0.25 mg - Plasma - agg. (n=10)",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (Itraconazole administered 24h before)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 311,
        "Title": "Varhe 1994",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Varhe 1994 - Triazolam 0.25 mg control",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Varhe 1994 - Triazolam with placebo - Triazolam - PO - 0.25 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Itraconazole)",
            "Symbol": "Circle"
          },
          {
            "Project": "Itraconazole-Triazolam-DDI",
            "Simulation": "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Varhe 1994 - Triazolam with Itraconazole - Triazolam - PO - 0.25 mg - Plasma - agg. (n=9)",
            "StartTime": 73,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Itraconazole)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 312,
        "Title": "Backman 1994",
        "SimulationDuration": 20,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Verapamil-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1994 - Midazolam with placebo - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Verapamil)",
            "Symbol": "Circle"
          },
          {
            "Project": "Verapamil-Midazolam-DDI",
            "Simulation": "DDI Treatment - Verapamil/Midazolam - Backman 1994",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1994 - Midazolam with verapamil - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 25,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Verapamil)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 312,
        "Title": "Wang 2005 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Verapamil-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Wang 2005",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Verapamil)",
            "Symbol": "Circle"
          },
          {
            "Project": "Verapamil-Midazolam-DDI",
            "Simulation": "DDI Treatment - Verapamil/Midazolam - Wang 2005",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 168,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Verapamil)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 312,
        "Title": "Wang 2005 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Verapamil-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Wang 2005",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Verapamil)",
            "Symbol": "Circle"
          },
          {
            "Project": "Verapamil-Midazolam-DDI",
            "Simulation": "DDI Treatment - Verapamil/Midazolam - Wang 2005",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 192,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Verapamil)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 313,
        "Title": "Kharasch 2012 IV",
        "SimulationDuration": 7.5,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Efavirenz-Alfentanil-DDI",
            "Simulation": "Kharasch 2012, Alfentanil IV alone",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2012 - Alfentanil IV alone - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Efavirenz)",
            "Symbol": "Circle"
          },
          {
            "Project": "Efavirenz-Alfentanil-DDI",
            "Simulation": "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2012 - Alfentanil IV + efavirenz - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 360.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Efavirenz",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 313,
        "Title": "Kharasch 2012 PO",
        "SimulationDuration": 8,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Efavirenz-Alfentanil-DDI",
            "Simulation": "Kharasch 2012, Alfentanil PO alone",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2012 - Alfentanil PO alone - Alfentanil - PO - 43 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Efavirenz)",
            "Symbol": "Circle"
          },
          {
            "Project": "Efavirenz-Alfentanil-DDI",
            "Simulation": "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2012 - Alfentanil PO + efavirenz - Alfentanil - PO - 43 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 336.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Efavirenz",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 314,
        "Title": "Mikus 2017 IV",
        "SimulationDuration": 9,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam alone",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Mikus 2017 - Midazolam control IV - Midazolam - IV - 2 mg - Plasma - agg. (n=12)",
            "StartTime": 6,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Efavirenz)",
            "Symbol": "Circle"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Mikus 2017 - Efavirenz + Midazolam IV day 1 - Midazolam - IV - 2 mg - Plasma - agg. (n=12)",
            "StartTime": 18,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Efavirenz), Day 1",
            "Symbol": "Square"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 138,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with Efavirenz), Day 6",
            "Symbol": "Triangle"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 258,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with Efavirenz), Day 11",
            "Symbol": "Diamond"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 378,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Treatment (with Efavirenz), Day 16",
            "Symbol": "Asterisk"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 522,
            "TimeUnit": "h",
            "Color": "#f0b7b2",
            "Caption": "Treatment (with Efavirenz), Day 22",
            "Symbol": ""
          }
        ]
      },
      {
        "SectionId": 314,
        "Title": "Mikus 2017 PO",
        "SimulationDuration": 6,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam alone",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Mikus 2017 - Midazolam control PO - Midazolam - PO - 4 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Efavirenz)",
            "Symbol": "Circle"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Mikus 2017 - Efavirenz + Midazolam PO day 1 - Midazolam - PO - 4 mg - Plasma - agg. (n=12)",
            "StartTime": 12,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Efavirenz",
            "Symbol": "Square"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with Efavirenz), Day 6",
            "Symbol": "Triangle"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 252,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with Efavirenz), Day 11",
            "Symbol": "Diamond"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 372,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Treatment (with Efavirenz), Day 16",
            "Symbol": "Asterisk"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 516,
            "TimeUnit": "h",
            "Color": "#f0b7b2",
            "Caption": "Treatment (with Efavirenz), Day 22",
            "Symbol": "Cross"
          }
        ]
      },
      {
        "SectionId": 314,
        "Title": "Katzenmaier 2010",
        "SimulationDuration": 10,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Katzenmaier 2010, Midazolam alone",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Katzenmaier 2010 - Midazolam control - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Efavirenz)",
            "Symbol": "Circle"
          },
          {
            "Project": "Efavirenz-Midazolam-DDI",
            "Simulation": "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Katzenmaier 2010 - Midazolam + Efavirenz - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 336,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Efavirenz",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 1997",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 1997 20 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Alfentanil - IV - 20 µg/kg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 1997 20 µg/kg IV and Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - with Perpetrator (Rifampicin) - Alfentanil - IV - 20 µg/kg - Plasma - agg. (n=9)",
            "StartTime": 120.5,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2004 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 15 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 15 µg/kg IV and Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 105,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2004 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 60 µg/kg PO - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 (60 µg/kg) Control (Perpetrator Placebo) - Alfentanil - PO - 60 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2004 60 µg/kg PO and Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 (60 µg/kg) with Perpetrator (Rifampicin) - Alfentanil - PO - 60 µg/kg - Plasma - agg. (n=10)",
            "StartTime": 129,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 109,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Alfentanil - PO - 75 µg/kg - Plasma - agg. (n=12)",
            "StartTime": 133,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (iv during sequential administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b IV 1mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Control sequential - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Rifampin coadmin sequential - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (iv during simultaneous administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b IV 1mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Control simultaneous - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 24,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil IV Rifampin coadmin simultaneous - Alfentanil - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (po during sequential administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b PO 4mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Control sequential - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Rifampin coadmin sequential - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 111,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Kharasch 2011b (po during simultaneous administration of iv unlabeled alfentanil and oral deuterated alfentanil)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b PO 4mg - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Control simultaneous - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 21,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011b - Alfentanil PO Rifampin coadmin simultaneous - Alfentanil - PO - 4 mg - Plasma - agg. (n=6)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 315,
        "Title": "Phimmasone 2001",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Phimmasone 2001 15 µg/kg IV - control",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alfentanil-DDI",
            "Simulation": "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Alfentanil - IV - 15 µg/kg - Plasma - agg. (n=6)",
            "StartTime": 107,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 316,
        "Title": "Gashaw 2003 (Day 7)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alprazolam-DDI",
            "Simulation": "Gashaw 2003 - Alprazolam control",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gashaw 2003 - Alprazolam 10h concentration before Rifampin treatment (control conditions, day 2) - Alprazolam - PO - 1 mg - Plasma - agg. (n=96)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alprazolam-DDI",
            "Simulation": "Gashaw 2003 - Alprazolam + Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gashaw 2003 - Alprazolam 10h concentration after Rifampin treatment (5 day rifampin treatment, day 7) - Alprazolam - PO - 1 mg - Plasma - agg. (n=96)",
            "StartTime": 100,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Rifampicin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 316,
        "Title": "Gashaw 2003 (after washout phase)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alprazolam-DDI",
            "Simulation": "Gashaw 2003 - Alprazolam control",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gashaw 2003 - Alprazolam 10h concentration before Rifampin treatment (control conditions, day 2) - Alprazolam - PO - 1 mg - Plasma - agg. (n=96)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alprazolam-DDI",
            "Simulation": "Gashaw 2003 - Alprazolam + Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gashaw 2003 - Alprazolam 10h concentration after wash out (day 22) - Alprazolam - PO - 1 mg - Plasma - agg. (n=96)",
            "StartTime": 436,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "After rifampicin washout phase",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 316,
        "Title": "Schmider 1999",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Alprazolam-DDI",
            "Simulation": "Schmider 1999 - Alprazolam control",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Schmider 1999 - Alprazolam alone - Alprazolam - PO - 1 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Alprazolam-DDI",
            "Simulation": "Schmider 1999 - Alprazolam + Rifampicin",
            "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Schmider 1999 - Alprazolam + Rifampin - Alprazolam - PO - 1 mg - Plasma - agg. (n=4 (17))",
            "StartTime": 96,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Rifampicin",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Backman 1996",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1996 - Control (Perpetrator Placebo) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1996 - with Perpetrator (Rifampicin) - Midazolam - PO - 15 mg - Plasma - agg. (n=10)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Backman 1998 (Phase IV and V vs. I)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase I (Control (Perpetrator Placebo)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase IV (during Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment Phase IV (with Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Backman 1998 - Phase V (4 days after Perpetrator (Rifampicin)) - Midazolam - PO - 15 mg - Plasma - agg. (n=9)",
            "StartTime": 185,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment Phase V (with Rifampicin)",
            "Symbol": "Diamond"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Chung 2006",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Chung 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Chung 2006 - Control (Perpetrator Placebo) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Chung 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 0.075 mg/kg - Plasma - agg. (n=18)",
            "StartTime": 166,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Eap 2004 (7.5 mg)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 7.5 mg Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=13)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Eap 2004 - 7.5 mg with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=4)",
            "StartTime": 114,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gorski 2003 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - iv Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Whole Blood - agg. (n=52)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gorski 2003 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - po Control (Perpetrator Placebo) - Midazolam - PO - 4 mg - Whole Blood - agg. (n=52)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
            "ObservedData": "Gorski 2003 - po with Perpetrator (Rifampicin) - Midazolam - PO - 6 mg - Whole Blood - agg. (n=52)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gurley 2006",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2006 - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=19)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Gurley 2008a",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Gurley 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - Control pre-Rifampicin (Perpetrator Placebo) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Gurley 2008a - with Perpetrator (Rifampicin) - Midazolam - PO - 8 mg - Plasma - agg. (n=16)",
            "StartTime": 146,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 1997",
        "SimulationDuration": 15,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 1997",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 1997 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - typical (n=9)",
            "StartTime": 120,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2004 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=10)",
            "StartTime": 104,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2004 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2004 - po #1 with Perpetrator (Rifampicin) - Midazolam - PO - 3 mg - Plasma - agg. (n=10)",
            "StartTime": 128,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2011 (iv)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 5 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 10 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 25 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - iv with Perpetrator (Rifampicin @ 75 mg) - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 108,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kharasch 2011 (po)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po Control (Perpetrator Placebo) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 5 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Treatment (with 5 mg Rifampicin)",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 10 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Treatment (with 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 25 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (with 25 mg Rifampicin)",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Kharasch 2011 - po with Perpetrator (Rifampicin @ 75 mg) - Midazolam - PO - 3 mg - Plasma - agg. (n=12)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with 75 mg Rifampicin)",
            "Symbol": "Asterisk"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Kim 2018",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Kim 2018 (male)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Link 2008 (iv)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - iv Control (Perpetrator Placebo) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - iv with Perpetrator (Rifampicin) - Midazolam - IV - 2 mg - Plasma - agg. (n=8)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Link 2008 (po)",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - po Control (Perpetrator Placebo) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Link 2008 - po with Perpetrator (Rifampicin) - Midazolam - PO - 7.5 mg - Plasma - agg. (n=8)",
            "StartTime": 144,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Phimmasone 2001",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - Control (Perpetrator Placebo) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Phimmasone 2001 - with Perpetrator (Rifampicin) - Midazolam - IV - 1 mg - Plasma - agg. (n=6)",
            "StartTime": 106,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Prueksaritanont 2017",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail alone - Midazolam - PO - 10 µg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Prueksaritanont 2017 - Midazolam in microdosecocktail + Rifampin - Midazolam - PO - 10 µg - Plasma - agg. (n=8)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Reitman 2011",
        "SimulationDuration": 15,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 0 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 648,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Week 0 after treatment with rifampicin",
            "Symbol": "Square"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 1 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 816,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Week 1 after treatment with rifampicin",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 2 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 984,
            "TimeUnit": "h",
            "Color": "#d6706b",
            "Caption": "Week 2 after treatment with rifampicin",
            "Symbol": "Diamond"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Reitman 2011 - Week 4 after Perpetrator (Rifampicin) - Midazolam - PO - 2 mg - Plasma - agg. (n=11)",
            "StartTime": 1320,
            "TimeUnit": "h",
            "Color": "#e4948e",
            "Caption": "Week 4 after treatment with rifampicin",
            "Symbol": "Circle"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Shin 2013",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Shin 2013",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2013 - Control phase (Midazolam alone) - Midazolam - IV - 1 mg - Plasma - agg. (n=24)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2013 - CYP3A4 induced phase (Midazolam + rifampicin) - Midazolam - IV - 2.5 mg - Plasma - agg. (n=24)",
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Shin 2016",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Shin 2016",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2016 - Midazolam alone - Midazolam - IV - 1 mg - Plasma - agg. (n=12)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Shin 2016 - Midazolam + rifampicin - Midazolam - IV - 2.5 mg - Plasma - agg. (n=12)",
            "StartTime": 216,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Szalat 2007",
        "SimulationDuration": 6,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Szalat 2007",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Szalat 2007 - Control (Perpetrator Placebo) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Szalat 2007 - with Perpetrator (Rifampicin) - Midazolam - IV - 0.05 mg/kg - Plasma - agg. (n=3)",
            "StartTime": 132,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "van Dyk 2018",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - van Dyk 2018",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "van Dyk 2018 - Midazolam in Caucasian at baseline - Midazolam - PO - 1 mg - Plasma - agg. (n=19)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": [],
            "StartTime": 156,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Wiesinger 2020",
        "SimulationDuration": 24,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Wiesinger 2020",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Wiesinger 2020 - Control phase (no RIF) - Midazolam - PO - 1 mg - Plasma - agg. (n=65)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Wiesinger 2020 - Weak-induction phase (RIF 10 mg) - Midazolam - PO - 1 mg - Plasma - agg. (n=65)",
            "StartTime": 180,
            "TimeUnit": "h",
            "Color": "#c54a4a",
            "Caption": "Treatment (low dose 10 mg Rifampicin)",
            "Symbol": "Triangle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Wiesinger 2020 - Strong-induction phase (RIF 600 mg) - Midazolam - PO - 1 mg - Plasma - agg. (n=65)",
            "StartTime": 444,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (high dose 600 mg Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 317,
        "Title": "Yu 2004 (CYP3A5*3/*3)",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yu 2004 - Control CYP3A5*3/*3 - Midazolam - IV - 1 mg - Plasma - agg. (n=7)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Midazolam-DDI",
            "Simulation": "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
            "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Yu 2004 - Treatment Rifampicin CYP3A5*3/*3 - Midazolam - IV - 2 mg - Plasma - agg. (n=7)",
            "StartTime": 240,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment (with Rifampicin)",
            "Symbol": "Square"
          }
        ]
      },
      {
        "SectionId": 318,
        "Title": "Villikka 1997",
        "SimulationDuration": 12,
        "TimeUnit": "h",
        "OutputMappings": [
          {
            "Project": "Rifampicin-Triazolam-DDI",
            "Simulation": "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Villikka 1997 - Triazolam + placebo - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)",
            "StartTime": 0,
            "TimeUnit": "h",
            "Color": "#2166ac",
            "Caption": "Control (without Rifampicin)",
            "Symbol": "Circle"
          },
          {
            "Project": "Rifampicin-Triazolam-DDI",
            "Simulation": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO",
            "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
            "ObservedData": "Villikka 1997 - Treatment arm (pretreatment with rifampin; 600 mg; 5 days) - Triazolam - PO - 0.5 mg - Plasma - agg. (n=10)",
            "StartTime": 113,
            "TimeUnit": "h",
            "Color": "#b2182b",
            "Caption": "Treatment with Rifampicin",
            "Symbol": "Square"
          }
        ]
      }
    ],
    "DDIRatioPlots": [
      {
        "SectionId": 2,
        "Title": "CYP3A4 DDI",
        "PKParameter": "AUC|CMAX",
        "PlotType": "predictedVsObserved|residualsVsObserved",
        "Artifacts": [
          "Plot",
          "GMFE",
          "Measure",
          "Table"
        ],
        "Groups": [
          {
            "Caption": "Clarithromycin + Midazolam (iv)",
            "Color": "#FF0000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 175,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Gorski 1998, Midazolam 0.05 mg/kg iv",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Gorski 1998, Midazolam 0.05 mg/kg iv, Clari 500 mg BID po, day 7",
                  "StartTime": 146,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2027,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - iv - Quinney 2008",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Clarithromycin/Midazolam - iv - Quinney 2008",
                  "StartTime": 146,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Clarithromycin + Midazolam (po)",
            "Color": "#FF0000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 173,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Gorski 1998, Midazolam 4 mg po",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Gorski 1998, Midazolam 4 mg po, Clari 500 mg BID po, day 7",
                  "StartTime": 146,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 217,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2006",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Clarithromycin/Midazolam - Gurley 2006",
                  "StartTime": 146,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 223,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2008a",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Clarithromycin/Midazolam - Gurley 2008a",
                  "StartTime": 146,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 354,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Markert 2013, Midazolam 3 mg po",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Markert 2013, Midazolam 3 mg po, Clari 500 mg BID po day 3",
                  "StartTime": 72.25,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1099,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Clarithromycin/Midazolam - Prueksaritanont 2017",
                  "StartTime": 72,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2030,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - po - Quinney 2008",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Clarithromycin/Midazolam - po - Quinney 2008",
                  "StartTime": 146,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2004,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - van Dyk 2018",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Clarithromycin/Midazolam - van Dyk 2018",
                  "StartTime": 324,
                  "EndTime": 330,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 469,
                "SimulationControl": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Yeates 1996, Midazolam 15 mg po",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Midazolam-DDI",
                  "Simulation": "Yeates 1996, Midazolam 15 mg po, Clari 250 mg BID po day 5",
                  "StartTime": 97.5,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Clarithromycin + Triazolam (po)",
            "Color": "#0000FF",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1102,
                "SimulationControl": {
                  "Project": "Clarithromycin-Triazolam-DDI",
                  "Simulation": "Greenblatt 1998a - Triazolam control - 0.125 mg PO SD",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Clarithromycin-Triazolam-DDI",
                  "Simulation": "Greenblatt 1998a - Clarithromycin 500 mg MD, Triazolam 0.125 mg PO",
                  "StartTime": 25,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Erythromycin + Alfentanil (iv)",
            "Color": "#008000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 779,
                "SimulationControl": {
                  "Project": "Erythromycin-Alfentanil-DDI",
                  "Simulation": "Bartkowski1989_Control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Alfentanil-DDI",
                  "Simulation": "Bartkowski1989_Perpetrator_Day1",
                  "StartTime": 1.5,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 780,
                "SimulationControl": {
                  "Project": "Erythromycin-Alfentanil-DDI",
                  "Simulation": "Bartkowski1989_Control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Alfentanil-DDI",
                  "Simulation": "Bartkowski1989_Perpetrator_Day7",
                  "StartTime": 145.5,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Erythromycin + Alprazolam (po)",
            "Color": "#FF00FF",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 777,
                "SimulationControl": {
                  "Project": "Erythromycin-Alprazolam-DDI",
                  "Simulation": "Yasui1996_Control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Alprazolam-DDI",
                  "Simulation": "Yasui1996_Perpetrator",
                  "StartTime": 170,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Erythromycin + Triazolam (po)",
            "Color": "#00C0C0",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 781,
                "SimulationControl": {
                  "Project": "Erythromycin-Triazolam-DDI",
                  "Simulation": "Greenblatt1998_Control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Triazolam-DDI",
                  "Simulation": "Greenblatt1998_Perpetrator",
                  "StartTime": 25,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 757,
                "SimulationControl": {
                  "Project": "Erythromycin-Triazolam-DDI",
                  "Simulation": "Phillips1986_Control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Triazolam-DDI",
                  "Simulation": "Phillips1986_Perpetrator",
                  "StartTime": 64,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Erythromycin + Midazolam (iv)",
            "Color": "#FF8000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 420,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Swart2002",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Swart2002",
                  "StartTime": 96,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 368,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Olkkola1993_IV",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Olkkola1993_IV",
                  "StartTime": 128,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Erythromycin + Midazolam (po)",
            "Color": "#FF8000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 366,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Olkkola1993_Oral",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Olkkola1993_Oral",
                  "StartTime": 128,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 471,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Zimmermann1996",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Zimmermann1996",
                  "StartTime": 97.5,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 362,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Okudaira2007_EM0",
                  "StartTime": 0,
                  "EndTime": 25,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Okudaira2007_EM2",
                  "StartTime": 25,
                  "EndTime": 73,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 363,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Okudaira2007_EM0",
                  "StartTime": 0,
                  "EndTime": 25,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Okudaira2007_EM4",
                  "StartTime": 73,
                  "EndTime": 145,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 364,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Okudaira2007_EM0",
                  "StartTime": 0,
                  "EndTime": 25,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Okudaira2007_EM7",
                  "StartTime": 145,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 828,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Carls2014",
                  "StartTime": 2,
                  "EndTime": 4,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Carls2014_250mg",
                  "StartTime": 3,
                  "EndTime": 5,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 829,
                "SimulationControl": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Control_Carls2014",
                  "StartTime": 2,
                  "EndTime": 4,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Erythromycin-Midazolam-DDI",
                  "Simulation": "Treatment_Carls2014_1000mg",
                  "StartTime": 3,
                  "EndTime": 5,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Fluvoxamine + Alprazolam (po)",
            "Color": "#C000C0",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1104,
                "SimulationControl": {
                  "Project": "Fluvoxamine-Alprazolam-DDI",
                  "Simulation": "Fleishaker1994_Alprazolam",
                  "StartTime": 0,
                  "EndTime": 5,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Fluvoxamine-Alprazolam-DDI",
                  "Simulation": "Fleishaker1994_Fluvoxamine_Alprazolam",
                  "StartTime": 144,
                  "EndTime": 149,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1113,
                "SimulationControl": {
                  "Project": "Fluvoxamine-Alprazolam-DDI",
                  "Simulation": "Fleishaker1994_Alprazolam",
                  "StartTime": 72,
                  "EndTime": 96,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Fluvoxamine-Alprazolam-DDI",
                  "Simulation": "Fleishaker1994_Fluvoxamine_Alprazolam",
                  "StartTime": 216,
                  "EndTime": 240,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Fluvoxamine + Midazolam (iv)",
            "Color": "#C04000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2007,
                "SimulationControl": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kashuba 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Fluvoxamine/Midazolam - Kashuba 1998",
                  "StartTime": 517,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Fluvoxamine + Midazolam (po)",
            "Color": "#C04000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1089,
                "SimulationControl": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "Lam 2003, 10 mg, SD, midazolam control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Fluvoxamine-Midazolam-DDI",
                  "Simulation": "Lam 2003, 10 mg SD, midazolam with fluvoxamine",
                  "StartTime": 265,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itraconazole + Alprazolam (po)",
            "Color": "#00FF00",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1026,
                "SimulationControl": {
                  "Project": "Itraconazole-Alprazolam-DDI",
                  "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with placebo",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Alprazolam-DDI",
                  "Simulation": "Yasui 1998 - Alprazolam 0.8 mg with itraconazole",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itraconazole + Midazolam (iv)",
            "Color": "#808080",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 378,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (iv, day 4)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 74,
                  "EndTime": 122,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 199,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Yu 2004 (CYP3A5 s3,s3)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
                  "StartTime": 72,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itraconazole + Midazolam (po)",
            "Color": "#808080",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 50,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Ahonen 1995",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Ahonen 1995",
                  "StartTime": 74,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 58,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
                  "StartTime": 74,
                  "EndTime": 170,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 59,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Backman 1998",
                  "StartTime": 170,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 370,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1994",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1994",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 377,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 2,
                  "EndTime": 74,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 379,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Olkkola 1996 (po, day 1 and 6)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Olkkola 1996",
                  "StartTime": 122,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1097,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Prueksaritanont 2017",
                  "StartTime": 72,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 424,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (50 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 425,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (200 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 426,
                "SimulationControl": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Templeton 2010",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Itraconazole/Midazolam - Templeton 2010 (400 mg)",
                  "StartTime": 4,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Itraconazole + Triazolam (po)",
            "Color": "#C0C000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1078,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg simultaneously",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1079,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 3 hrs before",
                  "StartTime": 3,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1080,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 12 hrs before",
                  "StartTime": 12,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1081,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Neuvonen 1996 - Triazolam 0.25 mg + ITZ 200 mg 24 hrs before",
                  "StartTime": 24,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1029,
                "SimulationControl": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Varhe 1994 - Triazolam 0.25 mg control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Itraconazole-Triazolam-DDI",
                  "Simulation": "Varhe 1994 - Triazolam 0.25 mg + Itraconazole 200 mg PO QD",
                  "StartTime": 73,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Verapamil + Midazolam (iv)",
            "Color": "#8080FF",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1111,
                "SimulationControl": {
                  "Project": "Verapamil-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Wang 2005",
                  "StartTime": 0,
                  "EndTime": 24,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Verapamil-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Verapamil/Midazolam - Wang 2005",
                  "StartTime": 168,
                  "EndTime": 192,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Verapamil + Midazolam (po)",
            "Color": "#8080FF",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1108,
                "SimulationControl": {
                  "Project": "Verapamil-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1994",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Verapamil-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Verapamil/Midazolam - Backman 1994",
                  "StartTime": 25,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1116,
                "SimulationControl": {
                  "Project": "Verapamil-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Wang 2005",
                  "StartTime": 24,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Verapamil-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Verapamil/Midazolam - Wang 2005",
                  "StartTime": 192,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Efavirenz + Alfentanil (iv)",
            "Color": "#0000C0",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 803,
                "SimulationControl": {
                  "Project": "Efavirenz-Alfentanil-DDI",
                  "Simulation": "Kharasch 2012, Alfentanil IV alone",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Alfentanil-DDI",
                  "Simulation": "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD",
                  "StartTime": 360.5,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Efavirenz + Alfentanil (po)",
            "Color": "#0000C0",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 801,
                "SimulationControl": {
                  "Project": "Efavirenz-Alfentanil-DDI",
                  "Simulation": "Kharasch 2012, Alfentanil PO alone",
                  "StartTime": 0,
                  "EndTime": 24,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Alfentanil-DDI",
                  "Simulation": "Kharasch 2012, Alfentanil + Efavirenz 600 mg OD",
                  "StartTime": 336.5,
                  "EndTime": 360.5,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Efavirenz + Midazolam (iv)",
            "Color": "#00C000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2045,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 6,
                  "EndTime": 14,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 18,
                  "EndTime": 26,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2048,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 6,
                  "EndTime": 14,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 138,
                  "EndTime": 146,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2050,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 6,
                  "EndTime": 14,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 258,
                  "EndTime": 266,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2052,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 6,
                  "EndTime": 14,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 378,
                  "EndTime": 386,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2054,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 6,
                  "EndTime": 14,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 522,
                  "EndTime": 530,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Efavirenz + Midazolam (po)",
            "Color": "#00C000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2041,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Katzenmaier 2010, Midazolam alone",
                  "StartTime": 0,
                  "EndTime": 10,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Katzenmaier 2010, Midazolam +  Efavirenz 400mg MD",
                  "StartTime": 336,
                  "EndTime": 340,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2044,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 12,
                  "EndTime": 18,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2047,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 132,
                  "EndTime": 138,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2049,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 252,
                  "EndTime": 258,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2051,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 372,
                  "EndTime": 378,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2053,
                "SimulationControl": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam alone",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Efavirenz-Midazolam-DDI",
                  "Simulation": "Mikus 2017, Midazolam + Efavirenz 400mg SD",
                  "StartTime": 516,
                  "EndTime": 522,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin + Alfentanil (iv)",
            "Color": "#C00000",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 278,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 1997 20 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 1997 20 µg/kg IV and Rifampicin",
                  "StartTime": 120.5,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 283,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 15 µg/kg IV and Rifampicin",
                  "StartTime": 105,
                  "EndTime": 129,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 299,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 5 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 300,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 10 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 301,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 25 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 302,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 15 µg/kg IV and 75 mg Rifampicin",
                  "StartTime": 109,
                  "EndTime": 133,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 763,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b IV 1mg - control",
                  "StartTime": 0,
                  "EndTime": 24,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 1 mg IV seq and 600 mg Rifampicin",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 767,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b IV 1mg - control",
                  "StartTime": 24,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 1 mg IV simultaneous and 600 mg Rifampicin",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 391,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Phimmasone 2001 15 µg/kg IV - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Phimmasone 2001 0.015 µg/kg IV and 600 mg Rifampicin",
                  "StartTime": 107,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin + Alfentanil (po)",
            "Color": "#C00000",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 288,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 60 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2004 60 µg/kg PO and Rifampicin",
                  "StartTime": 129,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 309,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 5 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 310,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 10 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 311,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 25 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 312,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO - control",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011 75 µg/kg PO and 75 mg Rifampicin",
                  "StartTime": 133,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 771,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b PO 4mg - control",
                  "StartTime": 0,
                  "EndTime": 21,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 4 mg PO seq and 600 mg Rifampicin",
                  "StartTime": 111,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alfentanil|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 775,
                "SimulationControl": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b PO 4mg - control",
                  "StartTime": 21,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alfentanil-DDI",
                  "Simulation": "Kharasch 2011b 4 mg PO simultaneous and 600 mg Rifampicin",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin + Alprazolam (po)",
            "Color": "#FFFF00",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2009,
                "SimulationControl": {
                  "Project": "Rifampicin-Alprazolam-DDI",
                  "Simulation": "Gashaw 2003 - Alprazolam control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alprazolam-DDI",
                  "Simulation": "Gashaw 2003 - Alprazolam + Rifampicin",
                  "StartTime": 100,
                  "EndTime": 436,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2010,
                "SimulationControl": {
                  "Project": "Rifampicin-Alprazolam-DDI",
                  "Simulation": "Gashaw 2003 - Alprazolam control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alprazolam-DDI",
                  "Simulation": "Gashaw 2003 - Alprazolam + Rifampicin",
                  "StartTime": 436,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Alprazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1001,
                "SimulationControl": {
                  "Project": "Rifampicin-Alprazolam-DDI",
                  "Simulation": "Schmider 1999 - Alprazolam control",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Alprazolam-DDI",
                  "Simulation": "Schmider 1999 - Alprazolam + Rifampicin",
                  "StartTime": 96,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin + Midazolam (iv)",
            "Color": "#008080",
            "Symbol": "Square",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 179,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gorski 2003 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (iv)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 276,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 1997",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 1997",
                  "StartTime": 120,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 280,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2004 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
                  "StartTime": 104,
                  "EndTime": 128,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 294,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 295,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 296,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 297,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
                  "StartTime": 108,
                  "EndTime": 132,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2036,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kim 2018 (male)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kim 2018 (male)",
                  "StartTime": 216,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 342,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Link 2008 (iv)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (iv)",
                  "StartTime": 144,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 389,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Phimmasone 2001",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Phimmasone 2001",
                  "StartTime": 106,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1092,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Shin 2013",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2013",
                  "StartTime": 216,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1095,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Shin 2016",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Shin 2016",
                  "StartTime": 216,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 422,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Szalat 2007",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Szalat 2007",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 202,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Yu 2018 (CYP3A5 s3,s3)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Yu 2004 (CYP3A5 s3,s3)",
                  "StartTime": 240,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin + Midazolam (po)",
            "Color": "#008080",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 54,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1996",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1996",
                  "StartTime": 113,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 56,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
                  "StartTime": 113,
                  "EndTime": 185,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 57,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Backman 1998",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Backman 1998",
                  "StartTime": 185,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 113,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Chung 2006",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Chung 2006",
                  "StartTime": 166,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 132,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Eap 2004 (7.5 mg)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Eap 2004",
                  "StartTime": 114,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Whole Blood (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 177,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gorski 2003 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gorski 2003 (po)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 215,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2006",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2006",
                  "StartTime": 146,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 221,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Gurley 2008",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Gurley 2008",
                  "StartTime": 146,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 286,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2004 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2004",
                  "StartTime": 128,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 304,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 5 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 305,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 10 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 306,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 25 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 307,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Kharasch 2011 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Kharasch 2011 (RIF @ 75 mg)",
                  "StartTime": 132,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 344,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Link 2008 (po)",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Link 2008 (po)",
                  "StartTime": 144,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1098,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Prueksaritanont 2017",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 392,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 648,
                  "EndTime": 816,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 393,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 816,
                  "EndTime": 984,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 394,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 1320,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Reitman 2011",
                  "StartTime": 984,
                  "EndTime": 1320,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 2002,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - van Dyk 2018",
                  "StartTime": 0,
                  "EndTime": 6,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - van Dyk 2018",
                  "StartTime": 156,
                  "EndTime": 162,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 204,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Wiesinger 2020",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020",
                  "StartTime": 180,
                  "EndTime": 444,
                  "TimeUnit": "h"
                }
              },
              {
                "Output": "Organism|PeripheralVenousBlood|Midazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 205,
                "SimulationControl": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Control - Midazolam - Wiesinger 2020",
                  "StartTime": 0,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Midazolam-DDI",
                  "Simulation": "DDI Treatment - Rifampicin/Midazolam - Wiesinger 2020",
                  "StartTime": 444,
                  "EndTime": 9999,
                  "TimeUnit": "h"
                }
              }
            ]
          },
          {
            "Caption": "Rifampicin + Triazolam (po)",
            "Color": "#800080",
            "Symbol": "Circle",
            "DDIRatios": [
              {
                "Output": "Organism|PeripheralVenousBlood|Triazolam|Plasma (Peripheral Venous Blood)",
                "ObservedData": "DDI Ratios",
                "ObservedDataRecordId": 1004,
                "SimulationControl": {
                  "Project": "Rifampicin-Triazolam-DDI",
                  "Simulation": "Villikka 1997 - Triazolam control - 0.5 mg SD PO",
                  "StartTime": 0,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                },
                "SimulationDDI": {
                  "Project": "Rifampicin-Triazolam-DDI",
                  "Simulation": "Villikka 1997 - Rifampicin 600 mg over 5 days and Triazolam 0.5 mg SD PO",
                  "StartTime": 113,
                  "EndTime": "Inf",
                  "TimeUnit": "h"
                }
              }
            ]
          }
        ]
      }
    ]
  },
  "Inputs": [],
  "Sections": [
    {
      "Id": 1,
      "Title": "1 Introduction",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md",
      "Sections": [
        {
          "Id": 11,
          "Title": "1.1 Objective",
          "Content": "Content/Qualification_DDI_CYP3A4_objective.md"
        },
        {
          "Id": 12,
          "Title": "1.2 CYP3A4 DDI Network",
          "Content": "Content/Qualification_DDI_CYP3A4_network_description.md",
          "Sections": [
            {
              "Id": 1201,
              "Title": "Clarithromycin - Midazolam DDI",
              "Content": "Content/Clarithromycin-Midazolam-DDI.md"
            },
            {
              "Id": 1202,
              "Title": "Clarithromycin - Triazolam DDI",
              "Content": "Content/Clarithromycin-Triazolam-DDI.md"
            },
            {
              "Id": 1203,
              "Title": "Erythromycin - Alfentanil DDI",
              "Content": "Content/Erythromycin-Alfentanil-DDI.md"
            },
            {
              "Id": 1204,
              "Title": "Erythromycin - Alprazolam DDI",
              "Content": "Content/Erythromycin-Alprazolam-DDI.md"
            },
            {
              "Id": 1205,
              "Title": "Erythromycin - Midazolam DDI",
              "Content": "Content/Erythromycin-Midazolam-DDI.md"
            },
            {
              "Id": 1206,
              "Title": "Erythromycin - Triazolam DDI",
              "Content": "Content/Erythromycin-Triazolam-DDI.md"
            },
            {
              "Id": 1207,
              "Title": "Fluvoxamine - Alprazolam DDI",
              "Content": "Content/Fluvoxamine-Alprazolam-DDI.md"
            },
            {
              "Id": 1208,
              "Title": "Fluvoxamine - Midazolam DDI",
              "Content": "Content/Fluvoxamine-Midazolam-DDI.md"
            },
            {
              "Id": 1209,
              "Title": "Itraconazole - Alprazolam DDI",
              "Content": "Content/Itraconazole-Alprazolam-DDI.md"
            },
            {
              "Id": 1210,
              "Title": "Itraconazole - Midazolam DDI",
              "Content": "Content/Itraconazole-Midazolam-DDI.md"
            },
            {
              "Id": 1211,
              "Title": "Itraconazole - Triazolam DDI",
              "Content": "Content/Itraconazole-Triazolam-DDI.md"
            },
            {
              "Id": 1212,
              "Title": "Verapamil - Midazolam DDI",
              "Content": "Content/Verapamil-Midazolam-DDI.md"
            },
            {
              "Id": 1213,
              "Title": "Efavirenz - Alfentanil-DDI",
              "Content": "Content/Efavirenz-Alfentanil-DDI.md"
            },
            {
              "Id": 1214,
              "Title": "Efavirenz - Midazolam DDI",
              "Content": "Content/Efavirenz-Midazolam-DDI.md"
            },
            {
              "Id": 1215,
              "Title": "Rifampicin - Alfentanil DDI",
              "Content": "Content/Rifampicin-Alfentanil-DDI.md"
            },
            {
              "Id": 1216,
              "Title": "Rifampicin - Alprazolam DDI",
              "Content": "Content/Rifampicin-Alprazolam-DDI.md"
            },
            {
              "Id": 1217,
              "Title": "Rifampicin - Midazolam DDI",
              "Content": "Content/Rifampicin-Midazolam-DDI.md"
            },
            {
              "Id": 1218,
              "Title": "Rifampicin - Triazolam DDI",
              "Content": "Content/Rifampicin-Triazolam-DDI.md"
            }
          ]
        }
      ]
    },
    {
      "Id": 2,
      "Title": "2 Qualification of Use Case CYP3A4-mediated DDI",
      "Content": "Content/Intro_evaluation_DDI_network.md"
    },
    {
      "Id": 3,
      "Title": "3 Concentration-Time Profiles",
      "Content": "Content/Intro_evaluation_CTprofiles.md",
      "Sections": [
        {
          "Id": 301,
          "Title": "3.1 Clarithromycin - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 302,
          "Title": "3.2 Clarithromycin - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 303,
          "Title": "3.3 Erythromycin - Alfentanil DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 304,
          "Title": "3.4 Erythromycin - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 305,
          "Title": "3.5 Erythromycin - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 306,
          "Title": "3.6 Erythromycin - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 307,
          "Title": "3.7 Fluvoxamine - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 308,
          "Title": "3.8 Fluvoxamine - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 309,
          "Title": "3.9 Itraconazole - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 310,
          "Title": "3.10 Itraconazole - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 311,
          "Title": "3.11 Itraconazole - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 312,
          "Title": "3.12 Verapamil - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 313,
          "Title": "3.13 Efavirenz - Alfentanil DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 314,
          "Title": "3.14 Efavirenz - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 315,
          "Title": "3.15 Rifampicin - Alfentanil DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 316,
          "Title": "3.16 Rifampicin - Alprazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 317,
          "Title": "3.17 Rifampicin - Midazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        },
        {
          "Id": 318,
          "Title": "3.18 Rifampicin - Triazolam DDI",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md"
        }
      ]
    },
    {
      "Id": 4,
      "Title": "4 References",
      "Content": "Content/References.md",
      "Sections": []
    },
    {
      "Id": 5,
      "Title": "5 Appendix",
      "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Empty.md",
      "Sections": [
        {
          "Id": 51,
          "Title": "5.1 Open Systems Pharmacology Suite (OSPS) Introduction",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/OSPS_Introduction.md"
        },
        {
          "Id": 52,
          "Title": "5.2 Mathematical Implementation of Drug-Drug Interactions",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Mathematical_Implementation_of_DDI.md"
        },
        {
          "Id": 53,
          "Title": "5.3 Automatic (re)-qualification workflow",
          "Content": "https://raw.githubusercontent.com/Open-Systems-Pharmacology/Qualification-text-modules/v1.0/Qualification_Workflow.md"
        }
      ]
    }
  ],
  "Intro": [
    {
      "Path": "Content/titlepage.md"
    }
  ]
}